Drug Recalls

"Drug Recalls" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Removal of a drug from the market due to a problem occurring in the manufacture or distribution of the product.

Descriptor ID

D056736

MeSH Number(s)

I01.880.604.605.250.625

N04.452.706.310.500

N06.850.210.637.200

Concept/Terms

Drug Recalls

Below are MeSH descriptors whose meaning is more general than "Drug Recalls".

Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Sociology [I01.880]
Social Control, Formal [I01.880.604]
Legislation, Drug [I01.880.604.605]
Drug and Narcotic Control [I01.880.604.605.250]
Drug Recalls [I01.880.604.605.250.625]
Health Care [N]
Health Services Administration [N04]
Organization and Administration [N04.452]
Pharmacy Administration [N04.452.706]
Drug and Narcotic Control [N04.452.706.310]
Drug Recalls [N04.452.706.310.500]
Environment and Public Health [N06]
Public Health [N06.850]
Consumer Product Safety [N06.850.210]
Product Recalls and Withdrawals [N06.850.210.637]
Drug Recalls [N06.850.210.637.200]

Below are MeSH descriptors whose meaning is related to "Drug Recalls".

Below are MeSH descriptors whose meaning is more specific than "Drug Recalls".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Recalls" by people in Harvard Catalyst Profiles by year, and whether "Drug Recalls" was a major or minor topic of these publication.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2011	0	1	1
2012	1	0	1
2013	1	0	1
2014	1	0	1
2019	0	1	1
2020	2	0	2
2022	1	0	1

Below are the most recent publications written about "Drug Recalls" by people in Profiles.

Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters. JAMA. 2022 07 26; 328(4):393-395.

View in: PubMed
Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare. Cardiovasc Drugs Ther. 2020 08; 34(4):579-584.

View in: PubMed
Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States. JAMA. 2020 01 07; 323(1):87-89.

View in: PubMed
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.

View in: PubMed
Extending Shelf Life Just Makes Sense. Mayo Clin Proc. 2015 Nov; 90(11):1471-4.

View in: PubMed
Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014 Oct 22-29; 312(16):1691-3.

View in: PubMed
Leveraging electronic health records to notify pediatric patients of a drug recall. JAMA Pediatr. 2013 Dec; 167(12):1170-1.

View in: PubMed
Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiol. 2012 Aug; 19(4):221-5.

View in: PubMed
The epidemiology of drug recalls in the United States. Arch Intern Med. 2012 Jul 23; 172(14):1109-10.

View in: PubMed
Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. J Gen Intern Med. 2012 Jan; 27(1):51-6.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

JAMA
Mayo Clin Proc
JAMA Pediatr
Cardiovasc Drugs Ther
Arch Intern Med
Pharmacogenomics J
Pharmacoepidemiol Drug Saf
Ophthalmic Epidemiol
J Gen Intern Med
Curr Med Res Opin